University Of Medicine And Dentistry Of New Jersey
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1970-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.umdnj.edu/
Trial to Enhance Adherence to Multiple Guidelines
- Conditions
- Cardiovascular DiseasesDiabetes MellitusHypertensionLung DiseasesAsthmaAtherosclerosisHeart Diseases
- Interventions
- Other: practice guideline adherence
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-07-11
- Target Recruit Count
- 60
- Registration Number
- NCT00201227
A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity
- Conditions
- Neurotoxicity Syndromes
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2009-12-11
- Target Recruit Count
- 20
- Registration Number
- NCT00176553
- Locations
- 🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2021-11-16
- Target Recruit Count
- 75
- Registration Number
- NCT00176592
- Locations
- 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States
A GameBoy as a Distraction Before Surgery in Children
- Conditions
- Anxiety
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-10-06
- Target Recruit Count
- 158
- Registration Number
- NCT00176670
- Locations
- 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-03-23
- Target Recruit Count
- 31
- Registration Number
- NCT00176488
- Locations
- 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
- Conditions
- OsteoporosisProstate Cancer
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-08-12
- Target Recruit Count
- 27
- Registration Number
- NCT00176579
- Locations
- 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
- Conditions
- SchizophreniaSchizoaffective DisorderSocial Anxiety Disorder
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2007-01-29
- Target Recruit Count
- 18
- Registration Number
- NCT00177008
- Locations
- 🇺🇸
Robert Wood Johnson Medical School - Psychiatry Dept., Piscataway, New Jersey, United States
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
- Conditions
- LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
- Interventions
- Biological: rituximabBiological: therapeutic allogeneic lymphocytes
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2013-09-17
- Target Recruit Count
- 2
- Registration Number
- NCT00176475
- Locations
- 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
- Conditions
- FatigueUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-05-17
- Target Recruit Count
- 30
- Registration Number
- NCT00176540
- Locations
- 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States
A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
- Conditions
- Oral Leukoplakia
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2009-12-11
- Target Recruit Count
- 8
- Registration Number
- NCT00176566
- Locations
- 🇺🇸
The Cancer Institute of New Jersey, New Brunswick, New Jersey, United States